Gugan Kaur advises life sciences clients on Food and Drug Administration (FDA) regulatory, compliance and enforcement issues. She provides counsel on matters throughout the product development process, including clinical trials, labeling and advertising, post-marketing, FDA inspections, and compliance and enforcement actions. She also advises clients on potential Federal Trade Commission (FTC) issues related to FDA-regulated products. Gugan has experience assisting clients in submitting trade complaints to FDA, FTC, the National Advertising Division (NAD) and the Electronic Retailing Self-Regulation Program (ERSP).
Prior to joining McDermott, Gugan was an associate at a boutique FDA-focused law firm. Previously, she served as a legal fellow in FDA’s Office of International Programs. During law school she served as an editor for the Boston University International Law Journal and interned in the compliance office at Tufts Medical Center in Boston. She was also the 2016 recipient of the American Bar Association’s Gellhorn-Sargentich Law Student Essay Award, for her essay “Indian Pharmaceutical Industry’s Compliance Problems with the United States Food and Drug Administration and Proposed Solutions.”